| Prognostic Significance of ASXL1 Mutations in Patients With Myelodysplastic Syndromes F Thol, I Friesen, F Damm, H Yun, EM Weissinger, J Krauter, K Wagner, ... Journal of Clinical Oncology 29 (18), 2499-2506, 2011 | 349 | 2011 |
| Compassionate use of sorafenib in FLT3-ITD–positive acute myeloid leukemia: sustained regression before and after allogeneic stem cell transplantation S Metzelder, Y Wang, E Wollmer, M Wanzel, S Teichler, A Chaturvedi, ... Blood, The Journal of the American Society of Hematology 113 (26), 6567-6571, 2009 | 315 | 2009 |
| Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML F Thol, R Gabdoulline, A Liebich, P Klement, J Schiller, C Kandziora, ... Blood, The Journal of the American Society of Hematology 132 (16), 1703-1713, 2018 | 286 | 2018 |
| Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML A Chaturvedi, MM Araujo Cruz, N Jyotsana, A Sharma, H Yun, K Görlich, ... Blood, The Journal of the American Society of Hematology 122 (16), 2877-2887, 2013 | 239 | 2013 |
| Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications F Thol, R Bollin, M Gehlhaar, C Walter, M Dugas, KJ Suchanek, ... Blood, The Journal of the American Society of Hematology 123 (6), 914-920, 2014 | 210 | 2014 |
| Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML) M Scherr, A Chaturvedi, K Battmer, I Dallmann, B Schultheis, A Ganser, ... Blood 107 (8), 3279-3287, 2006 | 147 | 2006 |
| Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo A Chaturvedi, L Herbst, S Pusch, L Klett, R Goparaju, D Stichel, ... Leukemia 31 (10), 2020-2028, 2017 | 132 | 2017 |
| Cell of origin in AML: susceptibility to MN1-induced transformation is regulated by the MEIS1/AbdB-like HOX protein complex M Heuser, H Yun, T Berg, E Yung, B Argiropoulos, F Kuchenbauer, ... Cancer cell 20 (1), 39-52, 2011 | 113 | 2011 |
| Impact of molecular genetics on outcome in myelofibrosis patients after allogeneic stem cell transplantation N Kröger, V Panagiota, A Badbaran, T Zabelina, I Triviai, MMA Cruz, ... Biology of Blood and Marrow Transplantation 23 (7), 1095-1101, 2017 | 107 | 2017 |
| Genetic deletion of SEPT7 reveals a cell type-specific role of septins in microtubule destabilization for the completion of cytokinesis MB Menon, A Sawada, A Chaturvedi, P Mishra, K Schuster-Gossler, ... PLoS genetics 10 (8), e1004558, 2014 | 95 | 2014 |
| Molecular simulations of the pressure, temperature, and chemical potential dependencies of clay swelling DE Smith, Y Wang, A Chaturvedi, HD Whitley The Journal of Physical Chemistry B 110 (40), 20046-20054, 2006 | 87 | 2006 |
| Vitamin C-induced epigenomic remodelling in IDH1 mutant acute myeloid leukaemia M Mingay, A Chaturvedi, M Bilenky, Q Cao, L Jackson, T Hui, M Moksa, ... Leukemia 32 (1), 11-20, 2018 | 82 | 2018 |
| Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo N Jyotsana, A Sharma, A Chaturvedi, R Budida, M Scherr, F Kuchenbauer, ... Annals of hematology 98, 1905-1918, 2019 | 71 | 2019 |
| Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation V Panagiota, F Thol, B Markus, B Fehse, H Alchalby, A Badbaran, ... Leukemia 28 (7), 1552-1555, 2014 | 71 | 2014 |
| Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations M Heuser, B Heida, K Büttner, CP Wienecke, K Teich, C Funke, ... Blood Advances 5 (9), 2294-2304, 2021 | 69 | 2021 |
| Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemia F Thol, C Winschel, AK Sonntag, F Damm, K Wagner, A Chaturvedi, ... Annals of hematology 92, 315-323, 2013 | 61 | 2013 |
| Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis F Thol, S Klesse, L Köhler, R Gabdoulline, A Kloos, A Liebich, ... Leukemia 31 (6), 1286-1295, 2017 | 60 | 2017 |
| Enantiomer-specific and paracrine leukemogenicity of mutant IDH metabolite 2-hydroxyglutarate A Chaturvedi, MM Araujo Cruz, N Jyotsana, A Sharma, R Goparaju, ... Leukemia 30 (8), 1708-1715, 2016 | 57 | 2016 |
| Prognostic Importance of Histone Methyltransferase MLL5 Expression in Acute Myeloid Leukemia F Damm, T Oberacker, F Thol, E Surdziel, K Wagner, A Chaturvedi, ... Journal of clinical oncology 29 (6), 682-689, 2011 | 54 | 2011 |
| Distinct splicing signatures affect converged pathways in myelodysplastic syndrome patients carrying mutations in different splicing regulators J Qiu, B Zhou, F Thol, Y Zhou, L Chen, C Shao, C DeBoever, J Hou, H Li, ... Rna 22 (10), 1535-1549, 2016 | 52 | 2016 |
Nidhi Jyotsana, Ph.D.Salk InstituteVerified email at salk.edu
